Suppr超能文献

孕中期生长速度:评估小于胎龄单胎胎儿的生长潜力

Second trimester growth velocities: assessment of fetal growth potential in SGA singletons.

作者信息

Deter Russell L, Lee Wesley, Kingdom John, Romero Roberto

机构信息

a Department of Obstetrics and Gynecology , Texas Children's Hospital, Baylor College of Medicine , Houston , TX , USA.

b Perinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research , Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health , Bethesda , MD and Detroit , MI , USA.

出版信息

J Matern Fetal Neonatal Med. 2019 Mar;32(6):939-946. doi: 10.1080/14767058.2017.1395849. Epub 2017 Nov 7.

Abstract

OBJECTIVE

To evaluate the validity of second trimester growth velocities as measures of fetal growth potential in Small-for-Gestational-Age (SGA) singletons.

METHODS

Second trimester growth velocities for biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC) and femur diaphysis length (FDL) were determined by linear regression analysis or direct measurement in 53 SGA singletons with normal growth outcomes (SGA N Group) and 73 with growth restriction (SGA GR) based on a composite fetal growth pathology score (FGPS1). The latter were subdivided into six groups based on their growth restriction pattern (Patterns group). Similar data were available for 118 singletons with normal neonatal growth outcomes (NNGO group). Coefficients of determination (R) and growth velocities for each anatomical parameter were compared between Patterns subgroups and the SGA N, SGA GR and NNGO groups.

RESULTS

Median R values in the six Patterns subgroups ranged from 98.2% (Pattern 2, FDL) to 99.9% (Pattern 5, AC). Within each anatomical parameter set, no significant differences were found (Kruskal-Wallis). Patterns subgroup data were pooled to form the SGA GR group for each anatomical parameter. Mean values for the three main groups ranged from 98.4% (SGA N, FDL) to 99.6% (SGA N, HC). No significant differences between groups (ANOVA) were found for any anatomical parameter (ANOVA). Only 1.7-3.8% had R values <95th%. No significant differences in median second trimester growth velocities among different Patterns subgroups were found for any anatomical parameter. In the SGA N and SGA GR groups, mean BPD and HC values did not differ but were significantly smaller than the NNGO group values. No differences in mean FDL values were seen. With AC, all three means were significantly different, having the following order: NNGO > SGA N > SGA GR. Of all 504 second trimester growth rates, 92.5% were within their respective 95% reference ranges.

CONCLUSION

Growth in the second trimester is linear in fetuses at risk for growth restriction. Except for FDL, growth velocities were lower than those for fetuses with NNGO. Only AC had mean velocities that differed between the SGA N and the SGA GR groups. Since most velocities (92.5%) were within normal reference ranges, they are reasonable measures of growth potential in fetuses at risk for growth restriction.

摘要

目的

评估孕中期生长速度作为小于胎龄(SGA)单胎胎儿生长潜能指标的有效性。

方法

通过线性回归分析或直接测量,确定了53例生长结局正常的SGA单胎(SGA N组)和73例基于综合胎儿生长病理评分(FGPS1)存在生长受限的SGA单胎(SGA GR组)的孕中期双顶径(BPD)、头围(HC)、腹围(AC)和股骨干长度(FDL)的生长速度。后者根据其生长受限模式分为六个组(模式组)。118例新生儿生长结局正常的单胎(NNGO组)也有类似数据。比较了模式亚组与SGA N组、SGA GR组和NNGO组之间各解剖参数的决定系数(R)和生长速度。

结果

六个模式亚组的中位数R值范围为98.2%(模式2,FDL)至99.9%(模式5,AC)。在每个解剖参数组内,未发现显著差异(Kruskal-Wallis检验)。将模式亚组数据合并形成每个解剖参数的SGA GR组。三个主要组的平均值范围为98.4%(SGA N组,FDL)至99.6%(SGA N组,HC)。对于任何解剖参数,各组之间均未发现显著差异(方差分析)。只有1.7 - 3.8%的R值<第95百分位数。对于任何解剖参数,不同模式亚组之间的孕中期生长速度中位数均未发现显著差异。在SGA N组和SGA GR组中,平均BPD和HC值无差异,但显著小于NNGO组的值。FDL平均值未见差异。对于AC,三个平均值均有显著差异,顺序如下:NNGO>SGA N>SGA GR。在所有504个孕中期生长率中,92.5%在各自的95%参考范围内。

结论

生长受限风险胎儿在孕中期的生长呈线性。除FDL外,生长速度低于新生儿生长结局正常的胎儿。只有AC在SGA N组和SGA GR组之间的平均速度存在差异。由于大多数速度(92.5%)在正常参考范围内,它们是生长受限风险胎儿生长潜能的合理指标。

相似文献

1
Second trimester growth velocities: assessment of fetal growth potential in SGA singletons.
J Matern Fetal Neonatal Med. 2019 Mar;32(6):939-946. doi: 10.1080/14767058.2017.1395849. Epub 2017 Nov 7.
2
Can growth in dichorionic twins be monitored with individualized growth assessment?
Ultrasound Obstet Gynecol. 2023 Dec;62(6):829-835. doi: 10.1002/uog.26320.
3
Third trimester growth restriction patterns: individualized assessment using a fetal growth pathology score.
J Matern Fetal Neonatal Med. 2018 Aug;31(16):2155-2163. doi: 10.1080/14767058.2017.1337741. Epub 2017 Jul 6.
4
Fetal growth pathology score: a novel ultrasound parameter for individualized assessment of third trimester growth abnormalities.
J Matern Fetal Neonatal Med. 2018 Apr;31(7):866-876. doi: 10.1080/14767058.2017.1300646. Epub 2017 Mar 20.
5
Individualized growth assessment in pregnancies complicated by fetal gastroschisis.
J Matern Fetal Neonatal Med. 2022 Dec;35(25):6842-6852. doi: 10.1080/14767058.2021.1926976. Epub 2021 Jun 7.
6
Growth patterns and cardiovascular abnormalities in SGA fetuses: 2. Normal growth and progressive growth restriction.
J Matern Fetal Neonatal Med. 2022 Jul;35(14):2818-2827. doi: 10.1080/14767058.2020.1807506. Epub 2020 Sep 13.
7
Second- to third-trimester longitudinal growth assessment for prediction of small-for-gestational age and late fetal growth restriction.
Ultrasound Obstet Gynecol. 2018 Feb;51(2):219-224. doi: 10.1002/uog.17471. Epub 2018 Jan 8.
8
Second-trimester growth velocities in twin and singleton pregnancies.
Ultrasound Obstet Gynecol. 2023 Jan;61(1):33-39. doi: 10.1002/uog.26102.
10
Classifying neonatal growth outcomes: use of birth weight, placental evaluation and individualized growth assessment.
J Matern Fetal Neonatal Med. 2016 Dec;29(24):3939-49. doi: 10.3109/14767058.2016.1157576. Epub 2016 Mar 21.

引用本文的文献

1
Ultrasound parameters of arteries and heart in normal fetuses.
Cardiovasc Ultrasound. 2024 Jul 29;22(1):9. doi: 10.1186/s12947-024-00328-w.
2
Maternal plasma syndecan-1: a biomarker for fetal growth restriction.
J Matern Fetal Neonatal Med. 2023 Dec;36(1):2150074. doi: 10.1080/14767058.2022.2150074.
3
Fetal growth velocity references from a Chinese population-based fetal growth study.
BMC Pregnancy Childbirth. 2021 Oct 9;21(1):688. doi: 10.1186/s12884-021-04149-x.

本文引用的文献

1
Third trimester growth restriction patterns: individualized assessment using a fetal growth pathology score.
J Matern Fetal Neonatal Med. 2018 Aug;31(16):2155-2163. doi: 10.1080/14767058.2017.1337741. Epub 2017 Jul 6.
2
Fetal growth pathology score: a novel ultrasound parameter for individualized assessment of third trimester growth abnormalities.
J Matern Fetal Neonatal Med. 2018 Apr;31(7):866-876. doi: 10.1080/14767058.2017.1300646. Epub 2017 Mar 20.
3
Classifying neonatal growth outcomes: use of birth weight, placental evaluation and individualized growth assessment.
J Matern Fetal Neonatal Med. 2016 Dec;29(24):3939-49. doi: 10.3109/14767058.2016.1157576. Epub 2016 Mar 21.
4
INTERGROWTH-21st vs customized birthweight standards for identification of perinatal mortality and morbidity.
Am J Obstet Gynecol. 2016 Apr;214(4):509.e1-509.e7. doi: 10.1016/j.ajog.2015.10.931. Epub 2015 Nov 4.
7
A modified prenatal growth assessment score for the evaluation of fetal growth in the third trimester using single and composite biometric parameters.
J Matern Fetal Neonatal Med. 2015 May;28(7):745-54. doi: 10.3109/14767058.2014.934218. Epub 2014 Jul 11.
8
Fetal growth cessation in late pregnancy: its impact on predicted size parameters used to classify small for gestational age neonates.
J Matern Fetal Neonatal Med. 2015 May;28(7):755-65. doi: 10.3109/14767058.2014.934219. Epub 2014 Jul 11.
9
Individualized fetal growth assessment: critical evaluation of key concepts in the specification of third trimester size trajectories.
J Matern Fetal Neonatal Med. 2014 Apr;27(6):543-51. doi: 10.3109/14767058.2013.833904. Epub 2013 Sep 12.
10
Assessing the value of customized birth weight percentiles.
Am J Epidemiol. 2011 Feb 15;173(4):459-67. doi: 10.1093/aje/kwq399. Epub 2010 Dec 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验